PharmaCorp Rx Inc.
PCRX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.00M | 8.96M | 19.75M | 15.93M | 1.52M |
| Total Receivables | 259.10K | 227.10K | 164.90K | 50.60K | -- |
| Inventory | 1.13M | 912.60K | 243.80K | 39.40K | -- |
| Prepaid Expenses | 22.40K | 33.40K | 47.70K | 15.40K | 700.00 |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 58.20K |
| Total Current Assets | 10.41M | 10.13M | 20.20M | 16.04M | 1.57M |
|
|
|||||
| Total Current Assets | 10.41M | 10.13M | 20.20M | 16.04M | 1.57M |
| Net Property, Plant & Equipment | 2.78M | 2.80M | 673.30K | 581.10K | -- |
| Long-term Investments | 7.98M | 7.98M | 1.43M | 460.50K | -- |
| Goodwill | 7.98M | 7.98M | 1.43M | 460.50K | -- |
| Total Other Intangibles | 3.48M | 3.57M | 1.44M | 639.10K | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 24.66M | 24.47M | 23.75M | 17.72M | 1.57M |
|
|
|||||
| Total Accounts Payable | 1.00M | 1.07M | 364.30K | 293.60K | 44.60K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 104.70K | 103.80K | 109.80K | 96.90K | -- |
| Total Finance Division Other Current Liabilities | 106.10K | 7.30K | -- | 6.80K | -- |
| Total Other Current Liabilities | 106.10K | 7.30K | -- | 6.80K | -- |
| Total Current Liabilities | 1.21M | 1.18M | 474.10K | 397.30K | 44.60K |
|
|
|||||
| Total Current Liabilities | 1.21M | 1.18M | 474.10K | 397.30K | 44.60K |
| Long-Term Debt | 208.30K | 221.20K | 249.50K | 260.00K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 324.40K | 337.40K | 373.40K | 300.30K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.47M | 1.49M | 390.70K | 265.30K | -- |
| Total Liabilities | 3.21M | 3.23M | 1.49M | 1.22M | 44.60K |
|
|
|||||
| Common Stock & APIC | 22.52M | 22.50M | 24.13M | 17.71M | 2.43M |
| Retained Earnings | -1.24M | -1.41M | -2.06M | -1.32M | -897.90K |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 21.28M | 21.09M | 22.07M | 16.38M | 1.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.28M | 21.09M | 22.07M | 16.38M | 1.53M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 163.40K | 154.60K | 186.90K | 113.70K | -- |
| Total Equity | 21.44M | 21.24M | 22.26M | 16.50M | 1.53M |
|
|
|||||